Latest Innovation News

GrainCorp reported a resilient FY25 with increased grain handling volumes and steady dividends, despite global margin pressures. The company’s strategic investments and operational efficiencies position it well for future growth.

Mount Hope Mining is set to recommence drilling at its Mt Solitary gold prospect in December, following a detailed reinterpretation of historical drill cores that confirms a 7.5km mineralised corridor linking Mt Solitary and Mt Solar.

Computershare Limited reported a robust FY25 performance with a 15% increase in management EPS and affirmed its FY26 guidance, underpinned by strategic technology investments and capital management initiatives.

EBR Systems has achieved a major commercial milestone with Medicare reimbursement approvals for its wireless cardiac pacing WiSE CRT System, driving a 201% revenue increase in Q3 2025. The company is advancing its Limited Market Release as it scales adoption in the US.

MyEco Group reveals a strategic pivot towards expanding its MyEco branded products, achieving a 9% sales increase in FY25, and implementing a $2.5 million cost-saving operational restructure aimed at EBITDA breakeven in FY26.

Orica Limited has delivered its strongest financial performance in over a decade, driven by premium product demand and digital innovation, while advancing ambitious sustainability targets. The company signals continued growth for 2026 despite emerging supply chain challenges.

Xero Limited reported a robust first half of FY26 with 20% revenue growth and strong cash generation, driven by sustained momentum across its core markets and the strategic Melio acquisition expanding its US footprint.

Unith Ltd has secured new contracts and expanded its strategic partnerships while advancing its ISO 27001 certification, signaling strong momentum in its AI digital human technology business.

AUB Group delivered a robust FY25 with a 17.1% rise in underlying net profit and a 15% dividend increase, while navigating a $45 per share acquisition proposal from an EQT-CVC consortium.

Immutep Limited’s Phase II EFTISARC-NEO trial reveals a novel immunotherapy combo delivering a striking 51.5% tumour response in soft tissue sarcoma patients, alongside robust immune activation signals.

Orica Limited reported a 6% increase in revenue to AUD 8.14 billion and a 23% rise in EBIT to AUD 992.2 million for FY2025, alongside record safety performance and significant strides in decarbonisation.

Xero Limited reports a robust 20% revenue increase in H1 FY26, driven by strong subscriber growth and the strategic Melio acquisition. The company’s innovative AI platform and improved profitability underscore its confident path toward accelerated US market expansion.